跳至主要内容
临床试验/NCT01623388
NCT01623388撤回不适用

Epigenetic Modifications Induced by Glycemic Variability

Scripps Translational Science Institute1 个研究点 分布在 1 个国家开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Evaluate blood sugar variability in Type I diabetics for differences in epigenetic signatures between Type I diabetics with little glycemic variability as compared to those with more pronounced glycemic changes.

研究概览

简要总结

This research is being done to find out if significant changes in blood glucose cause bad outcomes in patients with diabetes.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-65 years old
  • Diagnosis of Type I diabetes
  • Willing to wear continuous blood glucose monitor as specified in protocol

排除标准

  • Pregnant or planning to become pregnant during the study
  • Healthy control group Inclusion:
  • 18-65 years old
  • Willing to wear continuous blood glucose monitor as specified in protocol
  • Pregnant or planning to become pregnant during the study
  • Diagnosis of Type I or II Diabetes

结局指标

主要结局

Evaluate blood sugar variability in Type I diabetics for differences in epigenetic signatures between Type I diabetics with little glycemic variability as compared to those with more pronounced glycemic changes.

时间窗: 7 days

次要结局

未报告次要终点

研究者

发起方
Scripps Translational Science Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Topol, MD

Director

Scripps Translational Science Institute

研究点 (1)

Loading locations...

相似试验